12-6528950-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_014865.4(NCAPD2):c.3483C>T(p.Asn1161Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.275 in 1,613,344 control chromosomes in the GnomAD database, including 65,096 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.34 ( 9648 hom., cov: 32)
Exomes 𝑓: 0.27 ( 55448 hom. )
Consequence
NCAPD2
NM_014865.4 synonymous
NM_014865.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.19
Publications
29 publications found
Genes affected
NCAPD2 (HGNC:24305): (non-SMC condensin I complex subunit D2) Enables histone binding activity. Involved in mitotic chromosome condensation. Located in condensed chromosome; cytosol; and nucleoplasm. Part of condensin complex. Colocalizes with cytoplasm and nuclear chromosome. Implicated in primary autosomal recessive microcephaly. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 12-6528950-C-T is Benign according to our data. Variant chr12-6528950-C-T is described in ClinVar as Benign. ClinVar VariationId is 1321847.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.19 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.495 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.338 AC: 51373AN: 151930Hom.: 9633 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
51373
AN:
151930
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.303 AC: 76109AN: 251430 AF XY: 0.295 show subpopulations
GnomAD2 exomes
AF:
AC:
76109
AN:
251430
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.269 AC: 392959AN: 1461296Hom.: 55448 Cov.: 39 AF XY: 0.268 AC XY: 195083AN XY: 726996 show subpopulations
GnomAD4 exome
AF:
AC:
392959
AN:
1461296
Hom.:
Cov.:
39
AF XY:
AC XY:
195083
AN XY:
726996
show subpopulations
African (AFR)
AF:
AC:
17443
AN:
33470
American (AMR)
AF:
AC:
18176
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
10954
AN:
26134
East Asian (EAS)
AF:
AC:
8468
AN:
39700
South Asian (SAS)
AF:
AC:
21834
AN:
86248
European-Finnish (FIN)
AF:
AC:
12688
AN:
53420
Middle Eastern (MID)
AF:
AC:
2285
AN:
5742
European-Non Finnish (NFE)
AF:
AC:
283338
AN:
1111482
Other (OTH)
AF:
AC:
17773
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
14251
28501
42752
57002
71253
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
9678
19356
29034
38712
48390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.338 AC: 51425AN: 152048Hom.: 9648 Cov.: 32 AF XY: 0.336 AC XY: 24980AN XY: 74324 show subpopulations
GnomAD4 genome
AF:
AC:
51425
AN:
152048
Hom.:
Cov.:
32
AF XY:
AC XY:
24980
AN XY:
74324
show subpopulations
African (AFR)
AF:
AC:
20760
AN:
41450
American (AMR)
AF:
AC:
5416
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
AC:
1461
AN:
3468
East Asian (EAS)
AF:
AC:
1155
AN:
5160
South Asian (SAS)
AF:
AC:
1220
AN:
4820
European-Finnish (FIN)
AF:
AC:
2517
AN:
10584
Middle Eastern (MID)
AF:
AC:
104
AN:
292
European-Non Finnish (NFE)
AF:
AC:
17792
AN:
67970
Other (OTH)
AF:
AC:
772
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1663
3326
4989
6652
8315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
973
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Microcephaly 21, primary, autosomal recessive Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.